Mirna Mujacic
About Mirna Mujacic
Mirna Mujacic is a Director at Bristol Myers Squibb in Seattle, WA, with extensive experience in biologics and cell therapy process development. She has over a decade of experience in the biotechnology and pharmaceutical industry, having previously held leadership roles at Juno Therapeutics and Amgen.
Professional Experience at Bristol Myers Squibb
Mirna Mujacic currently holds the title of Director at Bristol Myers Squibb, based in Seattle, WA. She has been with the company since November 2019 and leads the CMC team for a BCMA CAR T-cell program. Her role involves significant responsibilities in biologics and cell therapy process development.
Previous Role at Juno Therapeutics, Inc.
Before joining Bristol Myers Squibb, Mirna Mujacic worked at Juno Therapeutics, Inc. in multiple capacities. She served as Director from 2018 to 2019, Associate Director from 2017 to 2018, and Senior Scientist from 2015 to 2017. Her work during these years contributed significantly to the advancement of cell therapies in the Greater Seattle Area.
Background in Biotechnology and Pharmaceuticals
Mirna Mujacic has over a decade of experience in the biotechnology and pharmaceutical industries. She has held several leadership roles in CMC and process development. Her positions at Amgen as Senior Scientist from 2012 to 2015, and Scientist from 2008 to 2012, are notable examples of her extensive background in biologics and cell therapy process development.
Educational Qualifications
Mirna Mujacic holds a Doctor of Philosophy (Ph.D.) in Bioengineering and Biomedical Engineering from the University of Washington, earned between 2001 and 2006. Additionally, she has a Bachelor of Science (B.S.) in Chemical Engineering from the same institution, achieved between 1996 and 2000. Her strong educational foundation supports her extensive expertise in the biotech field.
Early Career and Academic Roles
Mirna Mujacic began her career in the academic field as a Graduate Student on the Ph.D. track and Teaching Assistant in the Department of Bioengineering at the University of Washington from 2001 to 2006. She also worked as a Senior Associate Scientist (Contract Employee) at Amgen from 2006 to 2007 and a Scientist at ZymoGenetics from 2007 to 2008, both in the Greater Seattle Area.